SlideShare a Scribd company logo
1 of 36
Download to read offline
Capturing and creating value 
with biomarkers 
ACI Biomarker Utilisation & Commercialisation conference 
Dean Griffiths PhD 
5 September 2014 S4998-P-634 v1.0
Introduction to Cambridge Consultants - A world leader in technology and product innovation 
 Established out of The University of Cambridge in 1960 
 Approximately 430 scientists and engineers 
 For clients globally, we 
– design and develop breakthrough products 
– create and license intellectual property 
– provide business consulting in technology critical issues 
5 September 2014 2 S4998-P-634 v1.0
Summary 
Understand user needs 
Solutions require 
biomarker and platform 
Enable solutions which 
scale 
5 September 2014 3 S4998-P-634 v1.0
Agenda 
1 How do users benefit from biomarkers? 
2 Creating value by aligning to user needs 
3 Enabling user adoption 
4 Scaling user adoption 
5 Where next for biomarkers 
6 Summary 
5 September 2014 Commercially Confidential 4 S4998-P-634 v1.0
Researchers, clinicians and consumers 
5 September 2014 5 S4998-P-634 v1.0
Data, therapies and advice 
5 September 2014 6 S4998-P-634 v1.0
Agenda 
1 How do users benefit from biomarkers? 
2 Creating value by aligning to user needs 
3 Enabling user adoption 
4 Scaling user adoption 
5 Where next for biomarkers 
6 Summary 
5 September 2014 Commercially Confidential 7 S4998-P-634 v1.0
Creating value by aligning to user needs 
5 September 2014 8 S4998-P-634 v1.0
Creating value by aligning to user needs 
Biomarkers are not new; 
"Shushrut statue" by Alokprasad at en.wikipedia 
5 September 2014 9 S4998-P-634 v1.0
Creating value by aligning to user needs 
The need for biomarkers is growing as more targeted cancer therapies increase 
their market share 
Reproduced from (Aitken, 2014) 
5 September 2014 10 S4998-P-634 v1.0
Although many targeted cancer therapies still lack biomarkers 
16% 
48% 
2008 2013 
37% 
Drugs with FDA-approved 
CDx 
Drugs with FDA-approved 
biomarkers 
Other Drugs 
Creating value by aligning to user needs 
13% 
57% 
30% 
Cambridge Consultants analysis 2014 
5 September 2014 11 S4998-P-634 v1.0
Creating value by aligning to user needs 
5 September 2014 12 S4998-P-634 v1.0
Creating value by aligning to user needs 
5 September 2014 13 S4998-P-634 v1.0
Creating value by aligning to user needs 
Where are the tumour cells? 
Folate receptor-α 
targeted fluorescent agent 
Van Dam et al Nature Medicine 
17, 1315–1319 (2011) 
5 September 2014 14 S4998-P-634 v1.0
Creating value by aligning to user needs 
Where are the tumour cells? 
Folate receptor-α 
targeted fluorescent agent 
Van Dam et al Nature Medicine 
17, 1315–1319 (2011) 
5 September 2014 15 S4998-P-634 v1.0
Creating value by aligning to user needs 
Biomarkers used in vivo can detect more tumours 
Van Dam et al Nature Medicine 
17, 1315–1319 (2011) 
5 September 2014 16 S4998-P-634 v1.0
Creating value by aligning to user needs 
Multiple companies are already active in this space 
5 September 2014 17 S4998-P-634 v1.0
Agenda 
1 How do users benefit from biomarkers? 
2 Creating value by aligning to user needs 
3 Enabling user adoption 
4 Scaling user adoption 
5 Where next for biomarkers 
6 Summary 
5 September 2014 Commercially Confidential 18 S4998-P-634 v1.0
Enabling user adoption 
5 September 2014 19 S4998-P-634 v1.0
Enabling user adoption 
Demonstrate utility 
Image: Illumina 
5 September 2014 20 S4998-P-634 v1.0
Enabling user adoption 
Enable users to be able to access the platform and biomarkers 
The Economist 
5 September 2014 21 S4998-P-634 v1.0
Enabling user adoption 
Ensure that the platform and biomarker are easy to use and interpret 
Image: Illumina 
5 September 2014 22 S4998-P-634 v1.0
Enabling user adoption 
Information not just data 
Image: Illumina 
5 September 2014 23 S4998-P-634 v1.0
Agenda 
1 How do users benefit from biomarkers? 
2 Creating value by aligning to user needs 
3 Enabling user adoption 
4 Scaling user adoption 
5 Where next for biomarkers 
6 Summary 
5 September 2014 Commercially Confidential 24 S4998-P-634 v1.0
Scaling user adoption 
Scale is king 
5 September 2014 25 S4998-P-634 v1.0
Scaling user adoption 
5 September 2014 26 S4998-P-634 v1.0
Scaling user adoption 
Decrease barriers to entry 
Image: Abcam 
5 September 2014 27 S4998-P-634 v1.0
Scaling user adoption 
Increase data confidence 
Image: Abcam 
5 September 2014 28 S4998-P-634 v1.0
Scaling user adoption 
Generate publicity and goodwill 
Image: Abcam 
5 September 2014 29 S4998-P-634 v1.0
Agenda 
1 How do users benefit from biomarkers? 
2 Creating value by aligning to user needs 
3 Enabling user adoption 
4 Scaling user adoption 
5 Where next for biomarkers 
6 Summary 
5 September 2014 Commercially Confidential 30 S4998-P-634 v1.0
Where next for biomarkers 
New analytes 
Image: Senior Airman Sandra Welch 
5 September 2014 31 S4998-P-634 v1.0
Where next for biomarkers 
Non-invasive 
5 September 2014 32 S4998-P-634 v1.0
Where next for biomarkers 
Predictive 
Image: Sgt Eric T. Sheler - USAF 
5 September 2014 33 S4998-P-634 v1.0
Agenda 
1 How do users benefit from biomarkers? 
2 Creating value by aligning to user needs 
3 Enabling user adoption 
4 Scaling user adoption 
5 Where next for biomarkers 
6 Summary 
5 September 2014 Commercially Confidential 34 S4998-P-634 v1.0
Summary 
Understand user needs 
Solutions require 
biomarker and platform 
Enable solutions which 
scale 
5 September 2014 35 S4998-P-634 v1.0
Dean.Griffiths@Cambridgeconsultants.com 
+44 1223 392139 
Cambridge UK 
Registered No. 1036296 England 
Boston USA Singapore 
www.CambridgeConsultants.com 
Cambridge Consultants is part of the Altran group, a global leader 
in Innovation. www.Altran.com 
The contents of this presentation are commercially confidential and the 
proprietary information of Cambridge Consultants © 2014 Cambridge 
Consultants Ltd. All rights reserved. 
5 September 2014 S4998-P-634 v1.0

More Related Content

Similar to Creating and capturing value with biomarkers

Aneesh Chopra's Keynote at the Health 2.0's Provider Symposium
Aneesh Chopra's Keynote at the Health 2.0's Provider SymposiumAneesh Chopra's Keynote at the Health 2.0's Provider Symposium
Aneesh Chopra's Keynote at the Health 2.0's Provider Symposiumhealth2dev
 
Disposable Napkin Manufacturing Process PPT | Project Report 2023: Machinery,...
Disposable Napkin Manufacturing Process PPT | Project Report 2023: Machinery,...Disposable Napkin Manufacturing Process PPT | Project Report 2023: Machinery,...
Disposable Napkin Manufacturing Process PPT | Project Report 2023: Machinery,...IMARC Group
 
Product development phase project 2012
Product development phase project 2012Product development phase project 2012
Product development phase project 2012Njabulo Dube
 
PatNet Exploring Social Media and Bio-sensors for a Patient Driven Health Car...
PatNet Exploring Social Media and Bio-sensors for a Patient Driven Health Car...PatNet Exploring Social Media and Bio-sensors for a Patient Driven Health Car...
PatNet Exploring Social Media and Bio-sensors for a Patient Driven Health Car...nasim.mahmud
 
Bishwjit Ghoshal_Summer Internship Report 2015
Bishwjit Ghoshal_Summer Internship Report 2015Bishwjit Ghoshal_Summer Internship Report 2015
Bishwjit Ghoshal_Summer Internship Report 2015Bishwjit Ghoshal
 
Role of TGA Plenary session Sponsor Information and Training day
Role of TGA Plenary session Sponsor Information and Training dayRole of TGA Plenary session Sponsor Information and Training day
Role of TGA Plenary session Sponsor Information and Training dayTGA Australia
 
13 0730 session 1 webinar-techology_product validation
13 0730 session 1 webinar-techology_product validation13 0730 session 1 webinar-techology_product validation
13 0730 session 1 webinar-techology_product validationCleantechOpen
 
13 0730 session 1 webinar-techology_product validation
13 0730 session 1 webinar-techology_product validation13 0730 session 1 webinar-techology_product validation
13 0730 session 1 webinar-techology_product validationCleantechOpen
 
Consumer needs assessment of Aircare Products
Consumer needs assessment of Aircare ProductsConsumer needs assessment of Aircare Products
Consumer needs assessment of Aircare ProductsMurali Krishnan
 
SMi Group's Prefilled Syringes 2016
SMi Group's Prefilled Syringes 2016SMi Group's Prefilled Syringes 2016
SMi Group's Prefilled Syringes 2016Dale Butler
 
Telehealth Evolution & Revolution - James Hammond, Dell Healthcare / NTT Data...
Telehealth Evolution & Revolution - James Hammond, Dell Healthcare / NTT Data...Telehealth Evolution & Revolution - James Hammond, Dell Healthcare / NTT Data...
Telehealth Evolution & Revolution - James Hammond, Dell Healthcare / NTT Data...VSee
 
Digital health session 4 point of care testing 7th Dec 2016
Digital health session 4 point of care testing 7th Dec 2016Digital health session 4 point of care testing 7th Dec 2016
Digital health session 4 point of care testing 7th Dec 2016David Sandbach
 
HxRefactored - Mashery - Chuck Freedman
HxRefactored - Mashery - Chuck Freedman HxRefactored - Mashery - Chuck Freedman
HxRefactored - Mashery - Chuck Freedman HxRefactored
 
Setting Up a Successful Ipratropium (Atrovent) Manufacturing Unit: DPR
Setting Up a Successful Ipratropium (Atrovent) Manufacturing Unit: DPRSetting Up a Successful Ipratropium (Atrovent) Manufacturing Unit: DPR
Setting Up a Successful Ipratropium (Atrovent) Manufacturing Unit: DPRSmith Anderson
 
2015 market research report on global ivig industry
2015 market research report on global ivig industry2015 market research report on global ivig industry
2015 market research report on global ivig industryResearch Hub
 

Similar to Creating and capturing value with biomarkers (20)

Aneesh Chopra's Keynote at the Health 2.0's Provider Symposium
Aneesh Chopra's Keynote at the Health 2.0's Provider SymposiumAneesh Chopra's Keynote at the Health 2.0's Provider Symposium
Aneesh Chopra's Keynote at the Health 2.0's Provider Symposium
 
Setting the scene for wearables
Setting the scene for wearablesSetting the scene for wearables
Setting the scene for wearables
 
Disposable Napkin Manufacturing Process PPT | Project Report 2023: Machinery,...
Disposable Napkin Manufacturing Process PPT | Project Report 2023: Machinery,...Disposable Napkin Manufacturing Process PPT | Project Report 2023: Machinery,...
Disposable Napkin Manufacturing Process PPT | Project Report 2023: Machinery,...
 
TheFSM_Pilot_Foodakai.pptx
TheFSM_Pilot_Foodakai.pptxTheFSM_Pilot_Foodakai.pptx
TheFSM_Pilot_Foodakai.pptx
 
Product development phase project 2012
Product development phase project 2012Product development phase project 2012
Product development phase project 2012
 
PatNet Exploring Social Media and Bio-sensors for a Patient Driven Health Car...
PatNet Exploring Social Media and Bio-sensors for a Patient Driven Health Car...PatNet Exploring Social Media and Bio-sensors for a Patient Driven Health Car...
PatNet Exploring Social Media and Bio-sensors for a Patient Driven Health Car...
 
Bishwjit Ghoshal_Summer Internship Report 2015
Bishwjit Ghoshal_Summer Internship Report 2015Bishwjit Ghoshal_Summer Internship Report 2015
Bishwjit Ghoshal_Summer Internship Report 2015
 
Role of TGA Plenary session Sponsor Information and Training day
Role of TGA Plenary session Sponsor Information and Training dayRole of TGA Plenary session Sponsor Information and Training day
Role of TGA Plenary session Sponsor Information and Training day
 
13 0730 session 1 webinar-techology_product validation
13 0730 session 1 webinar-techology_product validation13 0730 session 1 webinar-techology_product validation
13 0730 session 1 webinar-techology_product validation
 
13 0730 session 1 webinar-techology_product validation
13 0730 session 1 webinar-techology_product validation13 0730 session 1 webinar-techology_product validation
13 0730 session 1 webinar-techology_product validation
 
Consumer needs assessment of Aircare Products
Consumer needs assessment of Aircare ProductsConsumer needs assessment of Aircare Products
Consumer needs assessment of Aircare Products
 
TheFSM_Pilot_FoodInspector.pptx
TheFSM_Pilot_FoodInspector.pptxTheFSM_Pilot_FoodInspector.pptx
TheFSM_Pilot_FoodInspector.pptx
 
SMi Group's Prefilled Syringes 2016
SMi Group's Prefilled Syringes 2016SMi Group's Prefilled Syringes 2016
SMi Group's Prefilled Syringes 2016
 
Telehealth Evolution & Revolution - James Hammond, Dell Healthcare / NTT Data...
Telehealth Evolution & Revolution - James Hammond, Dell Healthcare / NTT Data...Telehealth Evolution & Revolution - James Hammond, Dell Healthcare / NTT Data...
Telehealth Evolution & Revolution - James Hammond, Dell Healthcare / NTT Data...
 
Digital health session 4 point of care testing 7th Dec 2016
Digital health session 4 point of care testing 7th Dec 2016Digital health session 4 point of care testing 7th Dec 2016
Digital health session 4 point of care testing 7th Dec 2016
 
JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)
 
HxRefactored - Mashery - Chuck Freedman
HxRefactored - Mashery - Chuck Freedman HxRefactored - Mashery - Chuck Freedman
HxRefactored - Mashery - Chuck Freedman
 
TheFSM_WP6.pptx
TheFSM_WP6.pptxTheFSM_WP6.pptx
TheFSM_WP6.pptx
 
Setting Up a Successful Ipratropium (Atrovent) Manufacturing Unit: DPR
Setting Up a Successful Ipratropium (Atrovent) Manufacturing Unit: DPRSetting Up a Successful Ipratropium (Atrovent) Manufacturing Unit: DPR
Setting Up a Successful Ipratropium (Atrovent) Manufacturing Unit: DPR
 
2015 market research report on global ivig industry
2015 market research report on global ivig industry2015 market research report on global ivig industry
2015 market research report on global ivig industry
 

Recently uploaded

Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...IMARC Group
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Onlinelng ths
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsyasinnathani
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examplesamberjiles31
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access
 
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdfTalent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdfCharles Cotter, PhD
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Lviv Startup Club
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfHajeJanKamps
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinAnton Skornyakov
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfAnhNguyen97152
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGlokeshwarmaha
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...Brian Solis
 
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)tazeenaila12
 
Live-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarLive-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarNathanielSchmuck
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Reportamberjiles31
 
Tata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakTata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakEditores1
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024Stephan Koning
 
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxCracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxWorkforce Group
 

Recently uploaded (20)

Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Online
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story points
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examples
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024
 
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdfTalent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdf
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup Berlin
 
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdfGraham and Doddsville - Issue 1 - Winter 2006 (1).pdf
Graham and Doddsville - Issue 1 - Winter 2006 (1).pdf
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
 
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
Harvard Business Review.pptx | Navigating Labor Unrest (March-April 2024)
 
Live-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarLive-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry Webinar
 
WAM Corporate Presentation Mar 25 2024.pdf
WAM Corporate Presentation Mar 25 2024.pdfWAM Corporate Presentation Mar 25 2024.pdf
WAM Corporate Presentation Mar 25 2024.pdf
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Report
 
Investment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV IndustriesInvestment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV Industries
 
Tata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakTata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerak
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxCracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
 

Creating and capturing value with biomarkers

  • 1. Capturing and creating value with biomarkers ACI Biomarker Utilisation & Commercialisation conference Dean Griffiths PhD 5 September 2014 S4998-P-634 v1.0
  • 2. Introduction to Cambridge Consultants - A world leader in technology and product innovation  Established out of The University of Cambridge in 1960  Approximately 430 scientists and engineers  For clients globally, we – design and develop breakthrough products – create and license intellectual property – provide business consulting in technology critical issues 5 September 2014 2 S4998-P-634 v1.0
  • 3. Summary Understand user needs Solutions require biomarker and platform Enable solutions which scale 5 September 2014 3 S4998-P-634 v1.0
  • 4. Agenda 1 How do users benefit from biomarkers? 2 Creating value by aligning to user needs 3 Enabling user adoption 4 Scaling user adoption 5 Where next for biomarkers 6 Summary 5 September 2014 Commercially Confidential 4 S4998-P-634 v1.0
  • 5. Researchers, clinicians and consumers 5 September 2014 5 S4998-P-634 v1.0
  • 6. Data, therapies and advice 5 September 2014 6 S4998-P-634 v1.0
  • 7. Agenda 1 How do users benefit from biomarkers? 2 Creating value by aligning to user needs 3 Enabling user adoption 4 Scaling user adoption 5 Where next for biomarkers 6 Summary 5 September 2014 Commercially Confidential 7 S4998-P-634 v1.0
  • 8. Creating value by aligning to user needs 5 September 2014 8 S4998-P-634 v1.0
  • 9. Creating value by aligning to user needs Biomarkers are not new; "Shushrut statue" by Alokprasad at en.wikipedia 5 September 2014 9 S4998-P-634 v1.0
  • 10. Creating value by aligning to user needs The need for biomarkers is growing as more targeted cancer therapies increase their market share Reproduced from (Aitken, 2014) 5 September 2014 10 S4998-P-634 v1.0
  • 11. Although many targeted cancer therapies still lack biomarkers 16% 48% 2008 2013 37% Drugs with FDA-approved CDx Drugs with FDA-approved biomarkers Other Drugs Creating value by aligning to user needs 13% 57% 30% Cambridge Consultants analysis 2014 5 September 2014 11 S4998-P-634 v1.0
  • 12. Creating value by aligning to user needs 5 September 2014 12 S4998-P-634 v1.0
  • 13. Creating value by aligning to user needs 5 September 2014 13 S4998-P-634 v1.0
  • 14. Creating value by aligning to user needs Where are the tumour cells? Folate receptor-α targeted fluorescent agent Van Dam et al Nature Medicine 17, 1315–1319 (2011) 5 September 2014 14 S4998-P-634 v1.0
  • 15. Creating value by aligning to user needs Where are the tumour cells? Folate receptor-α targeted fluorescent agent Van Dam et al Nature Medicine 17, 1315–1319 (2011) 5 September 2014 15 S4998-P-634 v1.0
  • 16. Creating value by aligning to user needs Biomarkers used in vivo can detect more tumours Van Dam et al Nature Medicine 17, 1315–1319 (2011) 5 September 2014 16 S4998-P-634 v1.0
  • 17. Creating value by aligning to user needs Multiple companies are already active in this space 5 September 2014 17 S4998-P-634 v1.0
  • 18. Agenda 1 How do users benefit from biomarkers? 2 Creating value by aligning to user needs 3 Enabling user adoption 4 Scaling user adoption 5 Where next for biomarkers 6 Summary 5 September 2014 Commercially Confidential 18 S4998-P-634 v1.0
  • 19. Enabling user adoption 5 September 2014 19 S4998-P-634 v1.0
  • 20. Enabling user adoption Demonstrate utility Image: Illumina 5 September 2014 20 S4998-P-634 v1.0
  • 21. Enabling user adoption Enable users to be able to access the platform and biomarkers The Economist 5 September 2014 21 S4998-P-634 v1.0
  • 22. Enabling user adoption Ensure that the platform and biomarker are easy to use and interpret Image: Illumina 5 September 2014 22 S4998-P-634 v1.0
  • 23. Enabling user adoption Information not just data Image: Illumina 5 September 2014 23 S4998-P-634 v1.0
  • 24. Agenda 1 How do users benefit from biomarkers? 2 Creating value by aligning to user needs 3 Enabling user adoption 4 Scaling user adoption 5 Where next for biomarkers 6 Summary 5 September 2014 Commercially Confidential 24 S4998-P-634 v1.0
  • 25. Scaling user adoption Scale is king 5 September 2014 25 S4998-P-634 v1.0
  • 26. Scaling user adoption 5 September 2014 26 S4998-P-634 v1.0
  • 27. Scaling user adoption Decrease barriers to entry Image: Abcam 5 September 2014 27 S4998-P-634 v1.0
  • 28. Scaling user adoption Increase data confidence Image: Abcam 5 September 2014 28 S4998-P-634 v1.0
  • 29. Scaling user adoption Generate publicity and goodwill Image: Abcam 5 September 2014 29 S4998-P-634 v1.0
  • 30. Agenda 1 How do users benefit from biomarkers? 2 Creating value by aligning to user needs 3 Enabling user adoption 4 Scaling user adoption 5 Where next for biomarkers 6 Summary 5 September 2014 Commercially Confidential 30 S4998-P-634 v1.0
  • 31. Where next for biomarkers New analytes Image: Senior Airman Sandra Welch 5 September 2014 31 S4998-P-634 v1.0
  • 32. Where next for biomarkers Non-invasive 5 September 2014 32 S4998-P-634 v1.0
  • 33. Where next for biomarkers Predictive Image: Sgt Eric T. Sheler - USAF 5 September 2014 33 S4998-P-634 v1.0
  • 34. Agenda 1 How do users benefit from biomarkers? 2 Creating value by aligning to user needs 3 Enabling user adoption 4 Scaling user adoption 5 Where next for biomarkers 6 Summary 5 September 2014 Commercially Confidential 34 S4998-P-634 v1.0
  • 35. Summary Understand user needs Solutions require biomarker and platform Enable solutions which scale 5 September 2014 35 S4998-P-634 v1.0
  • 36. Dean.Griffiths@Cambridgeconsultants.com +44 1223 392139 Cambridge UK Registered No. 1036296 England Boston USA Singapore www.CambridgeConsultants.com Cambridge Consultants is part of the Altran group, a global leader in Innovation. www.Altran.com The contents of this presentation are commercially confidential and the proprietary information of Cambridge Consultants © 2014 Cambridge Consultants Ltd. All rights reserved. 5 September 2014 S4998-P-634 v1.0

Editor's Notes

  1. Biomarkers are used by 3 types of people All have different needs, the data, information, actions, advice, regulations Wearables leverage biomarkers
  2. Be mindful of what those needs are They could be discrete or mixed
  3. Biomarkers inform clinically actionable events Implementation is evolving in clinical practice
  4. Shushrut and Chakrat described a method for diagnosing what we now know as diabetes They described the sweetness of urine – first by taste, but also they quantified it. Counted the number of ants attracted.
  5. Bring things up to date Data from IMS show how the utilisation of cancer drugs is changing Targeted therapies as the name suggests hit a particular mutation Significant growth in targeted theratpies Decline in general cytotoxics Occuring in all areas; both developed ecomies and emerging economies
  6. However many of these therapies still lack an approved FDA diagnostic test, either as a lab test or a companion diagnostic Targeted therapies are only going to increase, pharma pipelines are bulging with targeted cancer therapies Immunotherapies – need for biomarkers, often used in combination with targeted therapies
  7. Switching gears; but sticking with cancer Pathologists tool kit use H&E staining to identify tumours Simple, reliable, inexpensive and accessible But while these data are useful for diagnosis and showing what has been removed
  8. They don’t show what should be removed Dissecting tumours to ensure that all the material is removed, while removing as little healthy tissue as possible improves outcomes
  9. But distinguising between healthy and cancerous tissue can be challenging Some may be able to identify some of the lumps here in a cervical cancer A trained eye may be able to idetify some more But wouldn’t it be better to use a biomarker, in vivo to distinguish normal and cancer cells
  10. Van Dam and colleagues used a folate receptor alpha targeted fluorescent agent Expressed on the surface of up to 95% of cervical cancers Readily highlights the cancer cells – enabling cleaner removal
  11. This experiment was done in humans – the first demonstration of in human efficacy When this was quantified there is a significant increase in number of lumps
  12. Lots of companies Dyes, Abs, imaging system, other optical techniques e.g. endofotonics and Raman – physical properties of the cells – parallels with circulating tumour cells detectio
  13. Illumina more than anyone else have changed the biomarker landscape over the last few years following the acquisition of Solexa This started in research, and continues in research however Illumina are targeting the clinical market as a significant growth area They woud like to provide the companion diagnostic for virtually every drug
  14. How are they doing it They are able to highlight stories about people Shelley Valiant – diagnosed that her phyciscial symptoms as a small child including poor motor control were due to mutation in neurotransmitter metabolism Using whole genome sequecing Dopamine
  15. Reduce cost of data – combination of reagents and instruments
  16. Make instruments easier to use Provide panels, enable panels to be made Bespoke or multiple companies now offfer cancer panels, infectious disease panels etc
  17. Don’t just give raw data
  18. Scale is the buzzword in the start up and investment community Talk to an executive from GE and if they don’t say scale they have not been there very long
  19. Abcam are actively scaling from a company started over a conversation about the cost and margins for antibodies at a dinner party to a globally recognised brand
  20. Knew who their customers were Phd students and postdocs Wanted to use the web – not some catalogue; it seems obvious now but 10 years ago this was changing the may research tools were sold Lots of themes from Amazon
  21. Researchers are price sensitive – abs were notorious for not working and there was nothing you could do about it. If you wanted a new Ab you might see what someone had published or ring a collegues Abcam gave you money back Reviews
  22. Got word out Tony Kouzarides wanted to get some winter sun
  23. VOCs
  24. X prize tricorder Scanadu Voice recognition for depression Gait analysis
  25. Can all speculate where this will go While it may not be gattaca growth of 23&me show public interest